(Q57109641)

English

Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study

scientific article published on 18 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Emilio Bajetta

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Laura Catena

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Pamela Biondani

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Giusi Blanco

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Sergio Ricci

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Francesca Pucci

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Monica Valente

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Nadia Bianco

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Chiara Maria Mauri

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Francesca Spada

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

language of work or name

0 references

publication date

18 April 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

120

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

2457-2463

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Everolimus for advanced pancreatic neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Activity of sunitinib in patients with advanced neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Current understanding of the molecular biology of pancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Everolimus in advanced pancreatic neuroendocrine tumors: the clinical experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

21 January 2018

Pancreatic neuroendocrine tumors: the impact of surgical resection on survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

7 January 2021

based on heuristic

inferred from DOI database lookup

mTOR activation in well differentiated pancreatic neuroendocrine tumors: a retrospective study on 34 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28726

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.28726

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24752410%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57109641&oldid=2131739541"